Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index

PurposeTo investigate the relationship between progression assessed by the visual field guided progression analysis (GPA) and rates of structural and functional change in glaucoma eyes.MethodsThis was a longitudinal observational study of 135 eyes of 97 patients with glaucoma followed for an average of 3.5 ± 0.9 years. All patients had standard automated perimetry (SAP) and retinal nerve fiber layer (RNFL) analysis with spectral domain optical coherence tomography (SDOCT), with an average of 6.8 ± 2.3 visits. A control group of healthy eyes followed longitudinally was used to estimate age-related change. Visual field progression was assessed using the Humphrey Field Analyzer GPA. Estimates of retinal ganglion cell counts from SAP and SDOCT were used to obtain a combined index of glaucomatous damage (RGC index) according to a previously described algorithm. Progression by SDOCT and the retinal ganglion cell (RGC) index were defined as statistically significant (P < 0.05) slopes of change that were also faster than age-related change estimated from healthy eyes.ResultsFrom the 135 eyes, 15 (11%) progressed by GPA, 21 (16%) progressed by SDOCT, and 31 (23%) progressed by the RGC index. Twenty-one eyes showed progression by the RGC index that was missed by the GPA. These eyes had an average rate of change in estimated RGC counts of − 28,910 cells/year, ranging from two to nine times faster than expected age-related losses.ConclusionMany glaucomatous eyes that are not found to be progressing by GPA may actually have fast rates of change as detected by a combined index of structure and function.

[1]  Shu Liu,et al.  Evaluation of retinal nerve fiber layer progression in glaucoma: a study on optical coherence tomography guided progression analysis. , 2010, Investigative ophthalmology & visual science.

[2]  F. Medeiros,et al.  Retinal ganglion cell count estimates associated with early development of visual field defects in glaucoma. , 2013, Ophthalmology.

[3]  F. Medeiros,et al.  Relationship between ganglion cell layer thickness and estimated retinal ganglion cell counts in the glaucomatous macula. , 2014, Ophthalmology (Rochester, Minn.).

[4]  F. Medeiros,et al.  Predicting progression in glaucoma suspects with longitudinal estimates of retinal ganglion cell counts. , 2013, Investigative ophthalmology & visual science.

[5]  M. Kass,et al.  Design and Baseline Description of the Participants , 1999 .

[6]  R. Harwerth,et al.  Visual field defects and retinal ganglion cell losses in patients with glaucoma. , 2006, Archives of ophthalmology.

[7]  R L Williams,et al.  A Note on Robust Variance Estimation for Cluster‐Correlated Data , 2000, Biometrics.

[8]  R. Harwerth,et al.  Linking structure and function in glaucoma , 2010, Progress in Retinal and Eye Research.

[9]  F. Medeiros,et al.  Estimated Rates of Retinal Ganglion Cell Loss in Glaucomatous Eyes with and without Optic Disc Hemorrhages , 2014, PloS one.

[10]  J. Katz,et al.  Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. , 1999, Ophthalmology.

[11]  W. Green,et al.  Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. , 1982, Archives of ophthalmology.

[12]  Robert N Weinreb,et al.  Estimating the rate of retinal ganglion cell loss in glaucoma. , 2012, American journal of ophthalmology.

[13]  G. Dunkelberger,et al.  Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. , 1989, American journal of ophthalmology.

[14]  S. Yun,et al.  Progression detection in different stages of glaucoma: mean deviation versus visual field index , 2012, Japanese Journal of Ophthalmology.

[15]  Robert N Weinreb,et al.  The relationship between cup-to-disc ratio and estimated number of retinal ganglion cells. , 2013, Investigative ophthalmology & visual science.

[16]  M. C. Leske,et al.  Measuring visual field progression in the Early Manifest Glaucoma Trial. , 2003, Acta ophthalmologica Scandinavica.

[17]  F. Medeiros,et al.  The pathophysiology and treatment of glaucoma: a review. , 2014, JAMA.

[18]  M. Kass,et al.  The Ocular Hypertension Treatment Study: design and baseline description of the participants. , 1999, Archives of ophthalmology.

[19]  F. Medeiros,et al.  A combined index of structure and function for staging glaucomatous damage. , 2012, Archives of ophthalmology.

[20]  Robert N Weinreb,et al.  The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change. , 2012, Investigative ophthalmology & visual science.